Get started
ASPEN PHARMACARE HLDGS LTDASPEN PHARMACARE HLDGS LTDASPEN PHARMACARE HLDGS LTD

ASPEN PHARMACARE HLDGS LTD

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

APN trade ideas

Aspen analysis Aspen had a positive week with a good rebound at R 107. This seems to be a good support line as the price is struggling a bit to go below this point. Currently sitting at R121, this could be a welcomed reset as we can expect the price to approach support again possibly in the new week depending on market sentiment overall. On the business end Aspen seems to be doing quite well, and we are certainly hoping this does reflect soon in terms of share price. From 105 to peak of 154, would yield a healthy 46% return which has a good chance of being realized in future. For now its a hold and those wanting to buy in would probably watch to see if a pull back is on the table.
JSE:APN
by AfroTez
Aspen Analysis Aspen with a strong rebound respecting the down trend support. Although its above the 105 support line, it can be expected it might dip below this point again. I feel in terms of long term portfolio growth a Pharma company is essential and this can be one big hitter when full year results are published especially considering the year they have had. Before the downtrend i let go of half of my holdings and i feel now is probably a decent time to start investing back into Aspen. This is a long term hold by the way. The current rally could be short lived and we could see a pull back soon. Although I am hoping that sooner or later we can go back to R140 price range.
JSE:APN
by AfroTez
Not sure what is driving the difference Aspen said the positive demand trends for Sterile Focus Brands used in the clinical management of Covid-19, the stockpiling of everyday healthcare products, and the advanced filling of prescriptions by consumers positively effected performance during the early and peak periods of Covid-19 infections across several regions. “These positive trends were more than offset by a decrease in demand as stock levels normalised, delays in the recovery of elective surgeries in most regions and reduced infection rates in non-Covid-19 communicable diseases due to social distancing,” Aspen said. I am not sure if this is sustainable
JSE:APN
by Mashithembe